Monitoring allograft health is an important component of posttransplant therapy.
Endomyocardial biopsy is the current gold standard for cardiac allograft monitoring but is an …

There are few substantive methods to measure the health of the immune system, and the
connection between immune strength and the viral component of the microbiome is poorly …

Despite modern immunosuppressive therapy, allograft rejection remains a major cause of
solid organ transplant dysfunction. For clinical care, organ transplant function is routinely …

Background: Endomyocardial biopsy (EMB) is the gold standard method for surveillance of
acute cardiac allograft rejection (ACAR) despite its invasive nature. Cardiovascular …

Introduction: Identification of allograft injury, including acute clinical and subclinical injury, is
vital in increasing the longevity of the transplanted organ. Acute rejection, which occurs as a …

Background The diagnosis of acute rejection in cardiac transplant recipients requires
invasive technique with endomyocardial biopsy (EMB) which has risks and limitations …

Background Exosomes are cell-derived circulating vesicles that play an important role in cell–
cell communication. Exosomes are actively assembled and carry messenger RNAs …

Background—The endomyocardial biopsy (EMB) is considered the gold standard in
rejection surveillance post cardiac transplant, but is invasive, with risk of complications. A …

Background Endomyocardial biopsy (EMB) facilitates a histopathologic diagnosis with
unique prognostic and therapeutic implications in both native and donor hearts. It is a …

Accurate and non-invasive monitoring of allograft posttransplant is essential for early
detection of acute cellular rejection and determines the long-term survival of the graft …